“Bayes Affinity Fingerprints” Improve Retrieval Rates in Virtual Screening and Define Orthogonal Bioactivity Space: When Are Multitarget Drugs a Feasible Concept?
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Conventional similarity searching of molecules compares single (or multiple) active query structures to each other in a relative framework, by means of a structural descriptor and a similarity measure. While this often works well, depending on the target, we show here that retrieval rates can be improved considerably by incorporating an external framework describing ligand bioactivity space for comparisons ("Bayes affinity fingerprints"). Structures are described by Bayes scores for a ligand panel comprising about 1000 activity classes extracted from the WOMBAT database. The comparison of structures is performed via the Pearson correlation coefficient of activity classes, that is, the order in which two structures are similar to the panel activity classes. Compound retrieval on a recently published data set could be improved by as much as 24% relative (9% absolute). Knowledge about the shape of the "bioactive chemical universe" is thus beneficial to identifying similar bioactivities. Principal component analysis was employed to further analyze activity space with the objective to define orthogonal ligand bioactive chemical space, leading to nine major (roughly orthogonal) activity axes. Employing only those nine activity classes, retrieval rates are still comparable to original Bayes affinity fingerprints; thus, the concept of orthogonal bioactive ligand chemical space was validated as being an information-rich but low-dimensional representation of bioactivity space. Correlations between activity classes are a major determinant to gauge whether the desired multitarget activity of drugs is (on the basis of current knowledge) a feasible concept because it measures the extent to which activities can be optimized independently, or only by strongly influencing one another.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there are theoretical grounds, as well as abundant evidence, to the effect that several steps in a network must be modulated simultaneously to exhibit substantial effects”
Citations
Cites
Handbook of Molecular Descriptors
Todeschini, R., & Consonni, V. (2000) · Methods and Principles in Medicinal Chemistry · doi:10.1002/9783527613106 · Cited by 4,107
The Properties of Known Drugs. 1. Molecular Frameworks
Bemis, G. W., & Murcko, M. A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9602928 · Cited by 2,482
Willett, P., Barnard, J. M., & Downs, G. M. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci9800211 · Cited by 1,765
Concepts and applications of molecular similarity
Johnson, M. A., & Maggiora, G. M. (1990) · Wiley eBooks · Cited by 1,301
An Information-Intensive Approach to the Molecular Pharmacology of Cancer
Weinstein, J. N., Myers, T. G., O'Connor, P. M., Friend, S. H., Fornace, A. J., Kohn, K. W., Fojo, T., Bates, S. E., Rubinstein, L. V., Anderson, N. L., et al. (1997) · Science · doi:10.1126/science.275.5298.343 · Cited by 1,183
From magic bullets to designed multiple ligands
Morphy, R., Kay, C., & Rankovic, Z. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03163-0 · Cited by 729
Molecular similarity: a key technique in molecular informatics
Bender, A., & Glen, R. C. (2004) · Organic & Biomolecular Chemistry · doi:10.1039/b409813g · Cited by 614
Self-citationCan we rationally design promiscuous drugs?
HOPKINS, A., MASON, J., & OVERINGTON, J. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.01.013 · Cited by 469
Nidhi, Glick, M., Davies, J. W., & Jenkins, J. L. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci060003g · Cited by 340
Self-citationHert, J., Willett, P., Wilton, D. J., Acklin, P., Azzaoui, K., Jacoby, E., & Schuffenhauer, A. (2004) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci034231b · Cited by 310
Research works printed but not linked: 12
- Bender A., 2006, Molecular Similarity: Advances in Methods, Applications and Validations in Virtual Screening and QSAR. Annu. Rep. Comput. Chem
- Willett P., 1999, Textual and Chemical Information Retrieval: Different Applications but Similar Algorithms. Inf. Res
- Bender A., 2004, J. Chem. Inf. Comput. Sci., 44, 1718
- Orld, 2006, http://www.sunsetmolecular.com/ (accessed
- Krejsa C. M., 2003, Curr. Opin. Drug Discovery Dev., 6, 480
- Karthikeyan M., 2005, J. Chem. Inf. Model., 45, 590
- Sheridan R. P., 2004, J. Chem. Inf. Comput. Sci., 44, 740
- PipelinePilot, 2006, http://www.scitegic.com/ (accessed
- Glen R. C., 2006, IDrugs, 9, 204
- Statistica, 2006, http://www.statsoft.com (accessed
- Good A. C., 2004, J. Comput.-Aided Mol. Des., 18, 536
- Zhang Q., 2006, J. Med. Chem., 49, 1548
Cited by
Extended-Connectivity Fingerprints
Rogers, D., & Hahn, M. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100050t · Cited by 7,524
Relating protein pharmacology by ligand chemistry
Keiser, M. J., Roth, B. L., Armbruster, B. N., Ernsberger, P., Irwin, J. J., & Shoichet, B. K. (2007) · Nature Biotechnology · doi:10.1038/nbt1284 · Cited by 2,402
Machine learning in chemoinformatics and drug discovery
Lo, Y.-C., Rensi, S. E., Torng, W., & Altman, R. B. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.05.010 · Cited by 960
Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches
Eckert, H., & Bajorath, J. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.01.011 · Cited by 466
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“…in a network must be modulated simultaneously to exhibit substantial effects (see e.g. Ágoston et al. 2005; Ambesi- Impiombato and di Bernardo 2006; Bender et al. 2006; Borisy et al. 2003; Csermely et al. 2005; Dancey and Chen 2006; Fan et al. 2003, 2006; Haggarty et al. 2003; Hopkins et al.…”
BackgroundBender, A., Scheiber, J., Glick, M., Davies, J. W., Azzaoui, K., Hamon, J., Urban, L., Whitebread, S., & Jenkins, J. L. (2007) · ChemMedChem · doi:10.1002/cmdc.200700026 · Cited by 327
Self-citationSelectively Nonselective Kinase Inhibition: Striking the Right Balance
Morphy, R. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901132v · Cited by 292
Koutsoukas, A., Simms, B., Kirchmair, J., Bond, P. J., Whitmore, A. V., Zimmer, S., Young, M. P., Jenkins, J. L., Glick, M., Glen, R. C., et al. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.05.011 · Cited by 287
Self-citationAn overview of molecular fingerprint similarity search in virtual screening
Muegge, I., & Mukherjee, P. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1117070 · Cited by 277
Chemogenomic approaches to rational drug design
Rognan, D. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707307 · Cited by 269
Bridging Chemical and Biological Space: “Target Fishing” Using 2D and 3D Molecular Descriptors
Nettles, J. H., Jenkins, J. L., Bender, A., Deng, Z., Davies, J. W., & Glick, M. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060902w · Cited by 201
Self-citationIn silico target fishing: Predicting biological targets from chemical structure
Jenkins, J. L., Bender, A., & Davies, J. W. (2006) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2006.12.008 · Cited by 189
Self-citationConcepts and applications of chemical fingerprint for hit and lead screening
Yang, J., Cai, Y., Zhao, K., Xie, H., & Chen, X. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103356 · Cited by 167
Structure‐Based Approaches to Target Fishing and Ligand Profiling
Rognan, D. (2010) · Molecular Informatics · doi:10.1002/minf.200900081 · Cited by 148
Compound promiscuity: what can we learn from current data?
Hu, Y., & Bajorath, J. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.03.002 · Cited by 161
Recent Advances in Machine-Learning-Based Chemoinformatics: A Comprehensive Review
Niazi, S. K., & Mariam, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411488 · Cited by 158
In-Silico Approaches to Multi-target Drug Discovery
Xiao, H., Shi, Z., Tan, C., Jiang, Y., Go, M., Low, B. C., & Chen, Y. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0065-2 · Cited by 153
Advances and Challenges in Computational Target Prediction
Sydow, D., Burggraaff, L., Szengel, A., van Vlijmen, H. W. T., IJzerman, A. P., van Westen, G. J. P., & Volkamer, A. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00832 · Cited by 126
The role of fragment-based and computational methods in polypharmacology
Bottegoni, G., Favia, A. D., Recanatini, M., & Cavalli, A. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.08.002 · Cited by 128
Nigsch, F., Bender, A., Jenkins, J. L., & Mitchell, J. B. O. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci800079x · Cited by 102
Self-citationJanga, S. C., & Tzakos, A. G. (2009) · Molecular BioSystems · doi:10.1039/b908147j · Cited by 110
Koutsoukas, A., Paricharak, S., Galloway, W. R. J. D., Spring, D. R., IJzerman, A. P., Glen, R. C., Marcus, D., & Bender, A. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400469u · Cited by 87
Self-citationEvolution of Novartis’ Small Molecule Screening Deck Design
Schuffenhauer, A., Schneider, N., Hintermann, S., Auld, D. S., Blank, J., Cotesta, S., Engeloch, C., Fechner, N., Gaul, C., Giovannoni, J., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01332 · Cited by 98
Weill, N., & Rognan, D. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800447g · Cited by 95
Chemical, Target, and Bioactive Properties of Allosteric Modulation
van Westen, G. J. P., Gaulton, A., & Overington, J. P. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003559 · Cited by 85
Banerjee, P., & Preißner, R. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00093 · Cited by 86
Bajusz, D., Rácz, A., & Héberger, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12345-5 · Cited by 84
Martin, É., Mukherjee, P. K., Sullivan, D. C., & Jansen, J. M. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci1005004 · Cited by 80
Drug profiling: knowing where it hits
Merino, A., Bronowska, A. K., Jackson, D., & Cahill, D. J. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.06.006 · Cited by 77
Wawer, M. J., Lounkine, E., Wassermann, A. M., & Bajorath, J. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.06.004 · Cited by 75
Kellenberger, E., Foata, N., & Rognan, D. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci800023x · Cited by 74
Chemical Fragments as Foundations for Understanding Target Space and Activity Prediction
Sutherland, J. J., Higgs, R. E., Watson, I., & Vieth, M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701399f · Cited by 71
Drug Effect Prediction by Polypharmacology-Based Interaction Profiling
Simon, Z., Peragovics, Á., Vigh-Smeller, M., Csukly, G., Tombor, L., Yang, Z., Zahoránszky-Köhalmi, G., Végner, L., Jelinek, B., Hári, P., et al. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci2002022 · Cited by 68
Which aspects of HTS are empirically correlated with downstream success?
Bender, A., Bojanic, D., Davies, J. W., Crisman, T. J., Mikhailov, D., Scheiber, J., Jenkins, J. L., Deng, Z., Hill, W. A., Popov, M., et al. (2008) · PubMed · Cited by 59
Self-citationDoadrio, A. L., Sánchez-Montero, J. M., Doadrio, J. C., Salinas, A. J., & Vallet‐Regí, M. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.11.002 · Cited by 57
van der Horst, E., Peironcely, J. E., IJzerman, A. P., Beukers, M. W., Lane, J. R., van Vlijmen, H. W., Emmerich, M., Okuno, Y., & Bender, A. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-316 · Cited by 53
Self-citationPimentel‐Elardo, S. M., Sørensen, D., Ho, L., Ziko, M., Bueler, S. A., Lu, S. M., Tao, J., Moser, A., Lee, R., Agard, D. A., et al. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00612 · Cited by 52
Škuta, C., Cortés‐Ciriano, I., Dehaen, W., Kříž, P., van Westen, G. J. P., Tetko, I. V., Bender, A., & Svozil, D. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00443-6 · Cited by 51
Self-citationHristozov, D., Oprea, T. I., & Gasteiger, J. (2007) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-007-9145-8 · Cited by 50
Mason, D. J., Eastman, R. T., Lewis, R. P. I., Stott, I. P., Guha, R., & Bender, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01096 · Cited by 42
Self-citationSeal, S., Yang, H., Trapotsi, M., Singh, S., Puigvert, J. C., Spjuth, O., & Bender, A. (2023) · Journal of Cheminformatics · doi:10.1186/s13321-023-00723-x · Cited by 44
Self-citationBayesian Methods in Virtual Screening and Chemical Biology
Bender, A. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-839-3_7 · Cited by 44
Self-citationBianchi, M. T., & Botzolakis, E. J. (2010) · BMC Pharmacology · doi:10.1186/1471-2210-10-3 · Cited by 43
Development and Testing of Druglike Screening Libraries
Wang, J., Ge, Y., & Xie, X. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00537 · Cited by 42
Predictive in silico Off-Target Profiling in Drug Discovery
Schmidt, F., Matter, H., Heßler, G., & Czich, A. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.13.202 · Cited by 42
Synergy Maps: exploring compound combinations using network-based visualization
Lewis, R., Guha, R., Korcsmáros, T., & Bender, A. (2015) · Journal of Cheminformatics · doi:10.1186/s13321-015-0090-6 · Cited by 39
Self-citationParicharak, S., Méndez‐Lucio, O., Ravindranath, A. C., Bender, A., IJzerman, A. P., & van Westen, G. J. P. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw105 · Cited by 39
Self-citationWassermann, A. M., Lounkine, E., & Glick, M. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci300607r · Cited by 38
Self-citationA resource for exploring the understudied human kinome for research and therapeutic opportunitiesPreprint
Moret, N., Liu, C., Gyori, B. M., Bachman, J. A., Steppi, A., Hug, C. B., Taujale, R., Huang, L., Berginski, M. E., Gomez, S. M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.02.022277 · Cited by 36
Ligand-Based Virtual Screening by Novelty Detection with Self-Organizing Maps
Hristozov, D., Oprea, T. I., & Gasteiger, J. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700040r · Cited by 34
QSAR-derived affinity fingerprints (part 2): modeling performance for potency prediction
Cortés‐Ciriano, I., Škuta, C., Bender, A., & Svozil, D. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00444-5 · Cited by 31
Self-citationCho, H., Shen, Q. “., Zhang, L. H., Okumura, M., Kawakami, A., Ambrose, J., Sigoillot, F. D., Miller, H., Gleim, S., Cobos‐Correa, A., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.03.004 · Cited by 30
Self-citationZhang, J., Han, B., Wei, X., Tan, C., Chen, Y., & Jiang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039076 · Cited by 27
Using Predicted Bioactivity Profiles to Improve Predictive Modeling
Norinder, U., Spjuth, O., & Svensson, F. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00250 · Cited by 27
Lounkine, E., Nigsch, F., Jenkins, J. L., & Glick, M. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci2004994 · Cited by 23
Self-citationvan der Horst, E., Peironcely, J. E., van Westen, G. J. P., van den Hoven, O. O., Galloway, W. R. J. D., Spring, D. R., Wegner, J. K., van Vlijmen, H., IJzerman, A. P., Overington, J. P., et al. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611796391230 · Cited by 24
Self-citationDrug Repurposing: Translational Pharmacology, Chemistry, Computers and the Clinic
Issa, N. T., Byers, S. W., & Dakshanamurthy, S. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113136660163 · Cited by 22
Nguyen, H. P., Koutsoukas, A., Fauzi, F. M., Drakakis, G., Maciejewski, M., Glen, R. C., & Bender, A. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12155 · Cited by 21
Self-citationVirtual Affinity Fingerprints for Target Fishing: A New Application of Drug Profile Matching
Peragovics, Á., Simon, Z., Tombor, L., Jelinek, B., Hári, P., Czobor, P., & Málnási‐Csizmadia, A. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci3004489 · Cited by 20
Peragovics, Á., Simon, Z., Brandhuber, I., Jelinek, B., Hári, P., Hetényi, C., Czobor, P., & Málnási‐Csizmadia, A. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci3001056 · Cited by 19
Bieler, M., Heilker, R., Köppen, H., & Schneider, G. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200105t · Cited by 18
Shi, Z., Ma, X. H., Qin, C., Jia, J., Jiang, Y., Tan, C., & Chen, Y. (2011) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2011.09.002 · Cited by 18
Experimental Confirmation of New Drug–Target Interactions Predicted by Drug Profile Matching
Végner, L., Peragovics, Á., Tombor, L., Jelinek, B., Czobor, P., Bender, A., Simon, Z., & Málnási‐Csizmadia, A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400813y · Cited by 18
Self-citationCHEMGENIE: integration of chemogenomics data for applications in chemical biology
Kutchukian, P. S., Chang, C., Fox, S., Cook, E. M., Barnard, R., Tellers, D. M., Wang, H., Pertusi, D. A., Glick, M., Sheridan, R. P., et al. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.09.004 · Cited by 15
Self-citationParicharak, S., IJzerman, A. P., Jenkins, J. L., Bender, A., & Nigsch, F. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00244 · Cited by 14
Self-citationChen, L., Qian, Z., Fen, K., & Cai, Y. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21467 · Cited by 14
Classifying Large Chemical Data Sets: Using A Regularized Potential Function Method
Mussa, H. Y., Hawizy, L., Nigsch, F., & Glen, R. C. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100022u · Cited by 13
Chemogenomics: Looking at biology through the lens of chemistry
Doddareddy, M. R., van Westen, G. J. P., van der Horst, E., Peironcely, J. E., Corthals, F., IJzerman, A. P., Emmerich, M., Jenkins, J. L., & Bender, A. (2009) · Statistical Analysis and Data Mining The ASA Data Science Journal · doi:10.1002/sam.10046 · Cited by 13
Self-citationSelectivity Data: Assessment, Predictions, Concordance, and Implications
Gao, C., Cahya, S., Nicolaou, C. A., Wang, J., Watson, I. A., Cummins, D. J., Iversen, P. W., & Vieth, M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400798j · Cited by 12
Morphy, R., & Ranković, Z. (2010) · Wiley eBooks · doi:10.1002/9780470584170.ch5 · Cited by 12
Multi-Assay-Based Compound Prioritization via Assistance Utilization: A Machine Learning Framework
Liu, J., & Ning, X. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00737 · Cited by 11
Ashenden, S. K. (2018) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.09.016 · Cited by 11
Large‐Scale QSAR in Target Prediction and Phenotypic HTS Assessment
Jenkins, J. L. (2012) · Molecular Informatics · doi:10.1002/minf.201200002 · Cited by 11
Self-citationNigsch, F., & Mitchell, J. B. O. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.05.007 · Cited by 10
Drug Design with Machine Learning
Ivanciuc, O. (2009) · Springer eBooks · doi:10.1007/978-0-387-30440-3_135 · Cited by 10
Differential Compound Prioritization via Bidirectional Selectivity Push with Power
Liu, J., & Ning, X. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00552 · Cited by 8
Historical Strategies for Lead Generation
Morphy, J. R. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734912-00111 · Cited by 8
In Silico Drug Discovery and Design
Lill, M. A. (2013) · doi:10.4155/9781909453012 · Cited by 8
Medicinal Chemistry Approaches for Multitarget Drugs
Morphy, R., & Ranković, Z. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc124 · Cited by 8
CHEMOMETRIC APPLICATIONS OF NAÏVE BAYESIAN MODELS IN DRUG DISCOVERY
Lounkine, E., Kutchukian, P. S., & Glick, M. (2013) · Wiley eBooks · doi:10.1002/9781118742785.ch7 · Cited by 7
Self-citationThe Interweaving of Cheminformatics and HTS
Kümmel, A., & Parker, C. N. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-839-3_17 · Cited by 6
Knott, S. D., Matten, S. R., & Staff, S. (2013) · Cited by 5
In Silico Prediction of Drug Side Effects
Keiser, M. J. (2015) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673643.ch02 · Cited by 5
Data Mining Using Ligand Profiling and Target Fishing
Bryant, S. D., & Langer, T. (2013) · Methods and principles in medicinal chemistry · doi:10.1002/9783527655984.ch11 · Cited by 5
Ashenden, S. K., Deswal, S., Bulusu, K. C., Bartosik, A., & Shameer, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820045-2.00004-0 · Cited by 4
Chemoinformatic approaches for navigating large chemical spaces
Vogt, M. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2313475 · Cited by 4
Contemporary Techniques for Target Deconvolution and Mode of Action Elucidation
Schirle, M., & Jenkins, J. L. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160721-00083 · Cited by 4
Self-citationUsing Artificial Intelligence for Drug Repurposing
Bender, A. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839163401-00147 · Cited by 4
Self-citationVieira, R., de Sousa, K. A., & Castro‐Gamboa, I. (2024) · Expert Systems with Applications · doi:10.1016/j.eswa.2024.123447 · Cited by 3
SAGPAR: Structural Grammar-based automated pathway reconstruction
Tagore, S., & De, R. K. (2012) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-012-0119-8 · Cited by 3
In Silico Lead Generation Approaches in Multi-Target Drug Discovery
Ma, X., & Chen, Y. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734912-00130 · Cited by 2
Knowledge‐Based and Computational Approaches to In Vitro Safety Pharmacology
Scheiber, J., Bender, A., Azzaoui, K., & Jenkins, J. L. (2009) · Methods and principles in medicinal chemistry · doi:10.1002/9783527627448.ch13 · Cited by 2
Self-citationChemoinformatic Approaches to Target Identification
Gregori‐Puigjané, E., & Keiser, M. J. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734912-00050 · Cited by 2
Computational methods for drug target profiling and polypharmacology
Langer, T., & Bryant, S. D. (2013) · doi:10.4155/ebo.13.417 · Cited by 2
Compound Structure‐Independent Activity Prediction in High‐Dimensional Target Space
Balfer, J., Hu, Y., & Bajorath, J. (2014) · Molecular Informatics · doi:10.1002/minf.201400051 · Cited by 2
Computer Aided Multi-target Drug Design, Multi-target Virtual Screening
Xiao, H., Shi, Z., Tan, C., Jiang, Y., Go, M., Low, B. C., & Chen, Y. (2010) · Cited by 2
Computational Approaches for Target Inference
Heßler, G., Grebner, C., & Matter, H. (2019) · Methods and principles in medicinal chemistry · doi:10.1002/9783527818242.ch10 · Cited by 2
Machine learning techniques applied to chemotaxonomy and ligand-based virtual screening
Hristozov, D. (2007) · Cited by 2
Development and Interpretation of Machine Learning Models for Drug Discovery
Balfer, J. (2015) · bonndoc (University of Bonn) · Cited by 2
Lead Discovery Using Virtual Screening
Bikker, J. A., & Narasimhan, L. S. (2009) · Topics in medicinal chemistry · doi:10.1007/7355_2009_3 · Cited by 1
Metadata
- Authors
- Bender, A., Jenkins, J. L., Glick, M., Deng, Z., Nettles, J. H., & Davies, J. W.
- Affiliations
- Novartis (United States) (US)
- Corresponding author
- Bender, Andreas
- Venue
- Journal of Chemical Information and Modeling
- Publisher
- American Chemical Society (ACS)
- Published
- 2006-09-09
- Volume
- 46
- Issue
- 6
- Pages
- 2445-2456
- ISSN
- 1549-9596 (ISSN-L)
- 1549-960X
- OpenAlex
- W2196714401
- Cited by
- 110
- References
- 25
- Citations by year
- 2024: 3 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 7 · 2019: 2 · 2018: 5 · 2017: 4 · 2016: 5 · 2015: 4 · 2014: 3 · 2013: 13 · 2012: 9
- FWCI
- 8.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Chemical Information and Modeling (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
- Keywords
- virtual screening, multi-target drugs, retrieval rate, principal component analysis, structure-activity relationship, similarity search
- MeSH terms
- Algorithms, Animals, Bayes Theorem, Chemistry, Chemistry, Pharmaceutical, Pharmaceutical Preparations, Humans, Ligands, Models, Chemical, Software, Drug Design, Molecular Structure, Databases, Factual, Principal Component Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.